1
Home
Companies

PeptiDream

#5631

Rank

$1.25B

Marketcap

JP Japan

Country

PeptiDream
Leadership team

Dr. Patrick Crawford Reid Ph.D. (Pres, CEO & Representative Director)

Dr. Kiyofumi Kaneshiro Ph.D. (CFO, Exec. VP & Director)

Dr. Keiichi Masuya Ph.D. (COO, Exec. VP & Director)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Tokyo, Tokyo, Japan
Established
2006
Net Income
2M - 5M
Revenue
20M - 100M
Traded as
4587.T
URL
https://www.peptidream.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
History

PeptiDream Inc. was established in 2006 to develop peptide-based therapeutics for the treatment of diseases caused by GPCRs. Since then, the company has established the world’s most advanced Peptide Discovery Platform technology, which enables the creation of a large library of optimized peptide molecules. The company has also established collaborative research agreements with several leading pharmaceutical companies. PeptiDream is focused on the discovery and development of innovative biopharmaceuticals to address unmet medical needs.

Mission
PeptiDream is dedicated to discovering, designing and developing peptide-based therapeutics that will address unmet medical needs and drive patient benefits.
Vision
PeptiDream’s vision is to be a leader in the creation and delivery of peptide-based therapeutics to improve patient outcomes.
Key Team

Toshiyuki Iwata (Head of Investor Relations)

Yuko Okimoto (Exec. Officer of IR PR Department)

Recognition and Awards
PeptiDream has been recognized by the Drug Information Association for its innovative research, development, and commercialization of peptide-based therapeutics, as well as its various collaborations with global biopharmaceutical companies.
References

https://in.investing.com/equities/peptidream-inc

https://finance.yahoo.com/quote/PPTDF/profile?p=PPTDF

https://www.crunchbase.com/organization/peptidream

https://companiesmarketcap.com/

https://www.peptidream.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

PeptiDream
Leadership team

Dr. Patrick Crawford Reid Ph.D. (Pres, CEO & Representative Director)

Dr. Kiyofumi Kaneshiro Ph.D. (CFO, Exec. VP & Director)

Dr. Keiichi Masuya Ph.D. (COO, Exec. VP & Director)

Products/ Services
Biotechnology, Health Care, Pharmaceutical
Number of Employees
500 - 1000
Headquarters
Tokyo, Tokyo, Japan
Established
2006
Net Income
2M - 5M
Revenue
20M - 100M
Traded as
4587.T
URL
https://www.peptidream.com